DrugNov 5, 2025
Endo USA Everolimus tablets 2.5 mg, 28 tablets recall — FDA D-0142-2026
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Class IIIFDA: OngoingEndo USA, Inc.
Recall history in this database
Classification mix: Class I: 5, Class III: 2.
DrugNov 5, 2025
Endo USA Everolimus tablets 10 mg, 28 tablets recall — FDA D-0141-2026
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
Class IIIFDA: OngoingEndo USA, Inc.
DrugFeb 12, 2025
ENDO USA Adrenalin Chloride Solution recall — FDA D-0223-2025
Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin (epinephrine injection, USP)
Class IFDA: OngoingENDO USA, Inc.
DrugJan 15, 2025
Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV recall — FDA D-0179-2025
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class IFDA: OngoingEndo USA, Inc.
DrugJan 15, 2025
Clonazepam Orally Disintegrating Tablets, USP, 1 mg, C-IV recall — FDA D-0181-2025
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class IFDA: OngoingEndo USA, Inc.
DrugJan 15, 2025
Clonazepam Orally Disintegrating Tablet, USP, 2 mg, C-IV recall — FDA D-0178-2025
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class IFDA: OngoingEndo USA, Inc.
DrugJan 15, 2025
Clonazepam Orally Disintegrating Tablets, USP, 0.25 mg, C-IV recall — FDA D-0180-2025
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Class IFDA: OngoingEndo USA, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Endo USA, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.